Advertisement
Canada markets open in 9 hours 30 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7303
    +0.0005 (+0.07%)
     
  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     
  • Bitcoin CAD

    88,023.26
    -3,181.25 (-3.49%)
     
  • CMC Crypto 200

    1,391.92
    -32.18 (-2.26%)
     
  • GOLD FUTURES

    2,325.10
    -13.30 (-0.57%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,460.75
    -203.75 (-1.15%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,739.10
    -720.98 (-1.87%)
     
  • CAD/EUR

    0.6819
    0.0000 (0.00%)
     

4 Marijuana Stocks Starting Strong on Monday (2/11/19)

CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / Though the marijuana stock market has only existed for a short period of time, it has managed to garner significant attention as companies in the space have worked to create new, innovative products for the cannabis consumer. We've seen, in recent months, an increase in supportive legislation put forth by politicians across the aisle, in favor of legalizing marijuana. As a result of this constant stream of legislation, investors looking to the cannabis sector are growing more excited. These investors are hungry for companies looking for new and innovative ways to incorporate medicinal/recreational cannabis into the lives of consumers. If the cannabis sector continues to earn more public approval, companies in the space may see investors paying closer attention in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Cronos Group Inc (NASDAQ: CRON, TSX: CRON), Aphria Inc (APHA), and Tilray Inc (TLRY) represent four pot stocks looking to kick off a strong week.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies used throughout the healthcare industry to create the best-possible care solutions for their growing patient network.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced towards the end of last week that the Company is now formally entering the cannabis clinic space. Premier's recent acquisition of Cloud Practice Inc has provided an underlying platform to help empower and streamline patient-doctor interaction. Whereas other clinics typically struggle with the labor-intensive process of onboarding patients, this will be done automatically with Premier's smart EMR.

The healthcare professional need only identify patients who could benefit from medical cannabis, and Premier Health Group (OTC:PHGRF) (CSE:PHGI)'s integrated technology will assess the patient's data, and through the use of analytics, output a comprehensive recommendation along with links to corresponding research relevant to the diagnosis.

ADVERTISEMENT

Dr. Essam Hamza, CEO of Premier Health Group (OTC:PHGRF) (CSE:PHGI), commented, "We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR). There has been a critical gap between the patient's need for medical cannabis and the doctor's knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem."

For More Information On Premier Health Group, Click Here

Cronos Group Inc (CRON) has enjoyed impressive gains as a result of the Company's announcement in early December 2018 that it had entered into a subscription agreement with Altria Group Inc, pursuant to which Altria has agreed to make n approximately C$2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the spatial of the Company.

Later this month, the Company will be holding a special meeting of holders of common shares of the Company, at which time Shareholders will be asked to approve both the investment and other matters ancillary to the investment.

For More Information on Cronos Group Inc, Click Here

Aphria Inc (APHA) made headlines last week that the Company, and its Board of Directors, decided to reject the hostile bid offer from Green Growth Brands Inc, which would see the latter acquire all outstanding shares of Aphria including any common shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, debentures or other securities of the Company exercisable or convertible into Common Shares, other than Common Shares owned by GGB or its affiliates, in exchange for 1.5714 shares of GGB.

Per the discussion held by the Company's board, the deal would have negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners, that could destroy value for Aphria shareholders, with minimal offsetting operational, financial or strategic benefits.

For More Information On Aphria Inc, Click Here

Tilray Inc (TLRY), a global leader in cannabis production, research, cultivation, and distribution, made an announcement towards the tail-end of last week regarding the expansion of its global senior leadership team. At the time of the announcement, the Company shared news of the appointment of Sascha Mielcarek as Managing Director, Europe.

Per the details of the appointment, Sascha Mielcarek comes to Tilray with over 18 years of experience in the pharmaceutical industry bringing extensive global commercial sales and marketing expertise in international markets such as the U.S., Europeand Latin America. Sascha most recently was at Grünenthal as Global Head of Gout Business Unit & Alliance Implementation Lead.

Brenden Kennedy, Tilray CEO, commented on the appointment, "Sascha brings an unmatched level of expertise from his years of experience in the European and global pharmaceutical industry and we're very pleased to welcome him to our team."

For More Information On Tilray Inc, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information:

news@stockprice.com

SOURCE: StockPrice.com



View source version on accesswire.com:
https://www.accesswire.com/534963/4-Marijuana-Stocks-Starting-Strong-on-Monday-21119